Breast Carcinoma trials recruiting in Minnesota

All Breast Carcinoma trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
  NCT05704283 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Female · Minnesota: Rochester
• A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction
  NCT07047872 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
  NCT06418204 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Albert Lea, Brainerd, Burnsville, Coon Rapids
• Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
  NCT06953245 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
  NCT06217874 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
  NCT07207564 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: Female · Minnesota: Rochester
• Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
  NCT05557877 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: Female · Minnesota: Rochester
• MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
  NCT06274034 · Phase: Early Phase 1 · Ages: 18 Years to 80 Years · Sex: Female · Minnesota: Rochester
• Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
  NCT06055881 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Minnesota: Rochester
• Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
  NCT04799535 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• The Vanguard Study: Testing a New Way to Screen for Cancer
  NCT06995898 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: All (male and female) · Minnesota: Minneapolis